Millons are impacted by hearing loss.
We're seeking to restore the clarity they've lost.

Learn More

Reimagining Treatments for Hearing Loss

More than 40 million people in the U.S. struggle with acquired sensorineural hearing loss, the most common type of hearing loss. This condition affects more than just hearing; it’s about communication and speech perception. Individuals may have difficulty speaking on the phone, struggle in school or at work and become socially isolated. What may start as a minor inconvenience can get progressively worse and is associated with other serious medical conditions like depression and dementia.

Current treatments can help make sounds louder, but we’re leading the creation of the first-ever disease-modifying therapy for sensorineural hearing loss — one that aims to restore hearing function and enhance the ability to clearly understand speech.

Learn More

Leading a New Category in Regenerative Medicine

With regenerative medicine, we often think of a complex, risky and multi-step process. Removing cells from the body, re-engineering genetic structures, using viruses or other carriers to help the modified genes reach their target – all while trying to do so safely.

At Frequency, we have created a simpler way to unlock the potential of regenerative medicine. Our approach aims to restore human function with small molecule therapeutics by activating a person’s innate regenerative potential within the body.

Learn More

Understanding Speech Perception

News & Insights

INSIGHT

August 23, 2021

Episode 2 of the Overheard at Frequency podcast, with guest Barbara Kelley of the Hearing Loss Association of America (HLAA).

Listen Now

NEWS

October 27, 2021

Frequency Therapeutics Virtual R&D Event to Detail FX-322 Clinical Advances, a New Program for Hearing Restoration and In Vivo Data from its MS Remyelination Program

Read More

NEWS

October 21, 2021

Frequency Therapeutics Announces First Subject Dosed in FX-322 Phase 2b Acquired Sensorineural Hearing Loss (SNHL) Study and FDA Agreement on Speech Perception as Primary Endpoint

Read More

Join Our Team

Learn more about Frequency, our team and culture, and opportunities to grow your career.

Learn More